Cardiovascular disease represents a continuum that starts with risk factors such as
hypertension and progresses to atherosclerosis, target organ damage, and ultimately to …

Cardiovascular disease represents a continuum that starts with risk factors, such as
hypertension, and progresses to atherosclerosis, target organ damage, and ultimately leads …

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs)
effectively interfere with the renin-angiotensin system and exert various beneficial actions on …

The renin-angiotensin system (RAS) plays a pivotal role in the progression of some forms of
hypertension and cardiovascular disease. The development of angiotensin-converting …

Despite a similar beneficial effect on blood pressure lowering observed with angiotensin-
converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor (AT1R) blocker …

Blockade of the renin–angiotensin system by angiotensin converting enzyme (ACE)
inhibitors reduces mortality and morbidity in patients post-myocardial infarction as well as in …

OBJECTIVE: To determine, through a review of the medical literature, whether there is
adequate evidence to support the use of angiotensin receptor blockers (ARBs) in place of …

Angiotensin receptor blockers (ARBs) were developed to better antagonize the effects of
chronic overactivation of angiotensin II. In clinical studies, ARBs have consistently been …

The cardiovascular continuum describes the progression of pathophysiologic events from
cardiovascular risk factors to symptomatic cardiovascular disease (CVD) and life-threatening …

The renin-angiotensin-aldosterone system (RAAS) is essential for the regulation of blood
pressure, cardiovascular and renal function. Drugs inhibiting the RAAS, particularly …